Tongkun Group（601233）株式概要同君集団有限公司は、中国でポリエステル長繊維の製造・販売を行っている。 詳細601233 ファンダメンタル分析スノーフレーク・スコア評価6/6将来の成長1/6過去の実績3/6財務の健全性2/6配当金3/6報酬当社が推定した公正価値より54.4%で取引されている 収益は年間19.94%増加すると予測されています 過去1年間で収益は169.3%増加しました 同業他社や業界と比較して、良好な取引価格 アナリストらは、株価が24.5%上昇するだろうとほぼ一致している。 リスク分析負債は営業キャッシュフローで十分にカバーされていない 財務結果に影響を与える大きな一時的項目 0.51%の配当はフリーキャッシュフローで十分にカバーされていない すべてのリスクチェックを見る601233 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW467,983 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA467,983 investors already sharing narrativesYour Fair ValueCN¥Current PriceCN¥23.334.3% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-2b129b2016201920222025202620282031Revenue CN¥129.2bEarnings CN¥4.4bAdvancedSet Fair ValueView all narrativesTongkun Group Co., Ltd. 競合他社Sichuan Em TechnologySymbol: SHSE:601208Market cap: CN¥48.9bYunnan Energy New Material (Group)Symbol: SZSE:002812Market cap: CN¥54.1bHuafon ChemicalLtdSymbol: SZSE:002064Market cap: CN¥57.2bRed Avenue New Materials GroupSymbol: SHSE:603650Market cap: CN¥39.6b価格と性能株価の高値、安値、推移の概要Tongkun Group過去の株価現在の株価CN¥23.3352週高値CN¥26.0152週安値CN¥12.36ベータ1.171ヶ月の変化20.82%3ヶ月変化10.73%1年変化85.60%3年間の変化62.35%5年間の変化-13.75%IPOからの変化119.87%最新ニュースValuation Update With 7 Day Price Move • Jul 13Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥19.31, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 37% over the past three years.Declared Dividend • Jul 06Dividend increased to CN¥0.12Dividend of CN¥0.12 is 20% higher than last year. Ex-date: 9th July 2026 Payment date: 9th July 2026 Dividend yield will be 0.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (9% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 5.3% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 52% over the next 3 years, which should provide support to the dividend and adequate earnings cover.New Risk • Jul 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.8% average weekly change). Large one-off items impacting financial results.お知らせ • Jun 30Tongkun Group Co., Ltd. to Report First Half, 2026 Results on Aug 26, 2026Tongkun Group Co., Ltd. announced that they will report first half, 2026 results on Aug 26, 2026Valuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥23.47, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 80% over the past three years.New Risk • May 09New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (9.0% average weekly change). Large one-off items impacting financial results.最新情報をもっと見るRecent updatesValuation Update With 7 Day Price Move • Jul 13Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥19.31, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 37% over the past three years.Declared Dividend • Jul 06Dividend increased to CN¥0.12Dividend of CN¥0.12 is 20% higher than last year. Ex-date: 9th July 2026 Payment date: 9th July 2026 Dividend yield will be 0.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (9% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 5.3% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 52% over the next 3 years, which should provide support to the dividend and adequate earnings cover.New Risk • Jul 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.8% average weekly change). Large one-off items impacting financial results.お知らせ • Jun 30Tongkun Group Co., Ltd. to Report First Half, 2026 Results on Aug 26, 2026Tongkun Group Co., Ltd. announced that they will report first half, 2026 results on Aug 26, 2026Valuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥23.47, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 80% over the past three years.New Risk • May 09New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (9.0% average weekly change). Large one-off items impacting financial results.Major Estimate Revision • May 05Consensus EPS estimates increase by 31%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from CN¥103.8b to CN¥113.5b. EPS estimate increased from CN¥1.36 to CN¥1.79 per share. Net income forecast to grow 32% next year vs 58% growth forecast for Chemicals industry in China. Consensus price target up from CN¥24.85 to CN¥27.74. Share price rose 16% to CN¥24.21 over the past week.Price Target Changed • Apr 30Price target increased by 12% to CN¥27.74Up from CN¥24.85, the current price target is an average from 4 analysts. New target price is 15% above last closing price of CN¥24.21. Stock is up 123% over the past year. The company is forecast to post earnings per share of CN¥1.79 for next year compared to CN¥0.86 last year.Reported Earnings • Apr 29First quarter 2026 earnings released: EPS: CN¥0.80 (vs CN¥0.26 in 1Q 2025)First quarter 2026 results: EPS: CN¥0.80 (up from CN¥0.26 in 1Q 2025). Revenue: CN¥23.4b (up 20% from 1Q 2025). Net income: CN¥1.90b (up 211% from 1Q 2025). Profit margin: 8.1% (up from 3.1% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.お知らせ • Apr 29Tongkun Group Co., Ltd., Annual General Meeting, May 20, 2026Tongkun Group Co., Ltd., Annual General Meeting, May 20, 2026, at 14:00 China Standard Time. Location: No. 518, Fenghuanghu Avenue, Tongxiang, Zhejiang Chinaお知らせ • Mar 30Tongkun Group Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026Tongkun Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026Valuation Update With 7 Day Price Move • Mar 09Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to CN¥20.46, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 25x in the Chemicals industry in China. Total returns to shareholders of 39% over the past three years.New Risk • Mar 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (8.7% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.8% average weekly change). Large one-off items impacting financial results.お知らせ • Dec 26Tongkun Group Co., Ltd. to Report Fiscal Year 2025 Results on Apr 22, 2026Tongkun Group Co., Ltd. announced that they will report fiscal year 2025 results on Apr 22, 2026Reported Earnings • Oct 30Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: EPS: CN¥0.19 (up from CN¥0.024 loss in 3Q 2024). Revenue: CN¥23.2b (down 17% from 3Q 2024). Net income: CN¥452.1m (up CN¥510.7m from 3Q 2024). Profit margin: 1.9% (up from net loss in 3Q 2024). Revenue missed analyst estimates by 5.0%. Earnings per share (EPS) also missed analyst estimates by 15%. Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.お知らせ • Sep 30Tongkun Group Co., Ltd. to Report Q3, 2025 Results on Oct 30, 2025Tongkun Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025Price Target Changed • Sep 17Price target increased by 8.8% to CN¥16.35Up from CN¥15.03, the current price target is an average from 4 analysts. New target price is 13% above last closing price of CN¥14.45. Stock is up 41% over the past year. The company is forecast to post earnings per share of CN¥0.94 for next year compared to CN¥0.51 last year.Price Target Changed • Aug 31Price target increased by 13% to CN¥15.53Up from CN¥13.71, the current price target is an average from 6 analysts. New target price is 5.8% above last closing price of CN¥14.67. Stock is up 23% over the past year. The company is forecast to post earnings per share of CN¥0.88 for next year compared to CN¥0.51 last year.Major Estimate Revision • Aug 30Consensus EPS estimates increase by 11%, revenue downgradedThe consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast fell from CN¥100.2b to CN¥91.3b. EPS estimate rose from CN¥0.821 to CN¥0.913. Net income forecast to grow 98% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target up from CN¥13.71 to CN¥14.56. Share price rose 2.8% to CN¥14.67 over the past week.Declared Dividend • Jul 06Dividend increased to CN¥0.10Dividend of CN¥0.10 is 133% higher than last year. Ex-date: 10th July 2025 Payment date: 10th July 2025 Dividend yield will be 0.9%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (19% earnings payout ratio) and cash flows (19% cash payout ratio). The dividend has increased by an average of 15% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 155% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Jun 30Tongkun Group Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025Tongkun Group Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025New Risk • Apr 30New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.2% Last year net profit margin: 2.1% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.8x net interest cover). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.2% net profit margin).New Risk • Apr 29New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 0.9% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.5x net interest cover). Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results.Reported Earnings • Apr 28Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2024 results: EPS: CN¥0.51 (up from CN¥0.34 in FY 2023). Revenue: CN¥101.3b (up 23% from FY 2023). Net income: CN¥1.20b (up 51% from FY 2023). Profit margin: 1.2% (up from 1.0% in FY 2023). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 6.6%. Earnings per share (EPS) missed analyst estimates by 9.0%. Revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance.お知らせ • Apr 26Tongkun Group Co., Ltd., Annual General Meeting, May 20, 2025Tongkun Group Co., Ltd., Annual General Meeting, May 20, 2025, at 14:00 China Standard Time. Location: No. 518, Fenghuanghu Avenue, Tongxiang, Zhejiang ChinaValuation Update With 7 Day Price Move • Apr 09Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥10.00, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 20x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years.お知らせ • Mar 28Tongkun Group Co., Ltd. to Report Q1, 2025 Results on Apr 30, 2025Tongkun Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 30, 2025お知らせ • Dec 27Tongkun Group Co., Ltd. to Report Fiscal Year 2024 Results on Apr 26, 2025Tongkun Group Co., Ltd. announced that they will report fiscal year 2024 results on Apr 26, 2025Major Estimate Revision • Nov 06Consensus EPS estimates fall by 41%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from CN¥93.3b to CN¥95.5b. EPS estimate fell from CN¥1.03 to CN¥0.612 per share. Net income forecast to grow 235% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target down from CN¥15.88 to CN¥15.13. Share price rose 4.0% to CN¥12.36 over the past week.Reported Earnings • Oct 31Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behindThird quarter 2024 results: CN¥0.024 loss per share (down from CN¥0.43 profit in 3Q 2023). Revenue: CN¥27.8b (up 12% from 3Q 2023). Net loss: CN¥58.6m (down 107% from profit in 3Q 2023). Revenue exceeded analyst estimates by 20%. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 5.5% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.お知らせ • Sep 30Tongkun Group Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024Tongkun Group Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥12.37, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 42% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥12.14 per share.Major Estimate Revision • Sep 04Consensus EPS estimates fall by 15%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate fell from CN¥1.24 to CN¥1.05 per share. Revenue forecast steady at CN¥92.0b. Net income forecast to grow 85% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target down from CN¥16.87 to CN¥15.88. Share price fell 2.1% to CN¥11.45 over the past week.Price Target Changed • Aug 30Price target decreased by 8.4% to CN¥15.45Down from CN¥16.87, the current price target is an average from 5 analysts. New target price is 30% above last closing price of CN¥11.89. Stock is down 22% over the past year. The company is forecast to post earnings per share of CN¥1.06 for next year compared to CN¥0.34 last year.Reported Earnings • Aug 29Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2024 results: EPS: CN¥0.21 (down from CN¥0.21 in 2Q 2023). Revenue: CN¥27.1b (up 29% from 2Q 2023). Net income: CN¥485.3m (down 19% from 2Q 2023). Profit margin: 1.8% (down from 2.8% in 2Q 2023). Revenue exceeded analyst estimates by 18%. Earnings per share (EPS) missed analyst estimates by 42%. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance.Buy Or Sell Opportunity • Jul 31Now 26% overvalued after recent price riseOver the last 90 days, the stock has risen 2.0% to CN¥14.05. The fair value is estimated to be CN¥11.12, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 15% in 2 years. Earnings are forecast to grow by 148% in the next 2 years.Buy Or Sell Opportunity • Jul 11Now 23% overvalued after recent price riseOver the last 90 days, the stock has risen 9.6% to CN¥15.06. The fair value is estimated to be CN¥12.19, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 14% in 2 years. Earnings are forecast to grow by 151% in the next 2 years.お知らせ • Jun 28Tongkun Group Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024Tongkun Group Co., Ltd. announced that they will report first half, 2024 results on Aug 29, 2024お知らせ • Apr 29Tongkun Group Co., Ltd., Annual General Meeting, May 21, 2024Tongkun Group Co., Ltd., Annual General Meeting, May 21, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Tongxiang, Zhejiang ChinaReported Earnings • Apr 27Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2023 results: EPS: CN¥0.34 (up from CN¥0.055 in FY 2022). Revenue: CN¥82.6b (up 33% from FY 2022). Net income: CN¥797.0m (up CN¥666.8m from FY 2022). Profit margin: 1.0% (up from 0.2% in FY 2022). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 4.4%. Earnings per share (EPS) missed analyst estimates by 48%. Revenue is forecast to grow 6.6% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 54 percentage points per year, which is a significant difference in performance.お知らせ • Mar 30Tongkun Group Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024Tongkun Group Co., Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024お知らせ • Dec 30Tongkun Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024Tongkun Group Co., Ltd. announced that they will report fiscal year 2023 results on Apr 27, 2024Reported Earnings • Oct 29Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behindThird quarter 2023 results: EPS: CN¥0.43 (up from CN¥0.15 loss in 3Q 2022). Revenue: CN¥24.8b (up 43% from 3Q 2022). Net income: CN¥798.3m (up CN¥1.16b from 3Q 2022). Profit margin: 3.2% (up from net loss in 3Q 2022). The move to profitability was driven by higher revenue. Revenue exceeded analyst estimates by 48%. Earnings per share (EPS) missed analyst estimates by 27%. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.お知らせ • Sep 30Tongkun Group Co., Ltd. to Report Q3, 2023 Results on Oct 28, 2023Tongkun Group Co., Ltd. announced that they will report Q3, 2023 results at 3:00 PM, China Standard Time on Oct 28, 2023New Risk • Sep 26New major risk - Revenue and earnings growthEarnings have declined by 1.7% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (16% operating cash flow to total debt). Earnings have declined by 1.7% per year over the past 5 years.Price Target Changed • Sep 19Price target increased by 8.6% to CN¥17.33Up from CN¥15.96, the current price target is an average from 8 analysts. New target price is 13% above last closing price of CN¥15.28. Stock is up 5.7% over the past year. The company is forecast to post earnings per share of CN¥0.80 for next year compared to CN¥0.055 last year.Price Target Changed • Sep 07Price target increased by 8.8% to CN¥16.82Up from CN¥15.46, the current price target is an average from 9 analysts. New target price is 9.8% above last closing price of CN¥15.32. Stock is up 3.9% over the past year. The company is forecast to post earnings per share of CN¥0.91 for next year compared to CN¥0.055 last year.Reported Earnings • Aug 30Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2023 results: EPS: CN¥0.21 (down from CN¥0.34 in 2Q 2022). Revenue: CN¥21.0b (up 25% from 2Q 2022). Net income: CN¥595.5m (down 25% from 2Q 2022). Profit margin: 2.8% (down from 4.7% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 75%. Earnings per share (EPS) missed analyst estimates by 54%. Revenue is forecast to grow 9.9% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.お知らせ • Jun 28Tongkun Group Co., Ltd. to Report First Half, 2023 Results on Aug 30, 2023Tongkun Group Co., Ltd. announced that they will report first half, 2023 results on Aug 30, 2023Price Target Changed • May 29Price target decreased by 10% to CN¥14.56Down from CN¥16.26, the current price target is an average from 6 analysts. New target price is 20% above last closing price of CN¥12.13. Stock is down 28% over the past year. The company is forecast to post earnings per share of CN¥1.30 for next year compared to CN¥0.055 last year.Price Target Changed • May 12Price target decreased by 7.3% to CN¥15.08Down from CN¥16.26, the current price target is an average from 6 analysts. New target price is 19% above last closing price of CN¥12.72. Stock is down 17% over the past year. The company is forecast to post earnings per share of CN¥1.36 for next year compared to CN¥0.055 last year.Reported Earnings • Apr 26Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: CN¥0.055 (down from CN¥3.23 in FY 2021). Revenue: CN¥62.0b (up 4.8% from FY 2021). Net income: CN¥130.2m (down 98% from FY 2021). Profit margin: 0.2% (down from 13% in FY 2021). Revenue missed analyst estimates by 2.7%. Earnings per share (EPS) also missed analyst estimates by 93%. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 4% per year and the company’s share price has also increased by 4% per year.Major Estimate Revision • Apr 23Consensus EPS estimates fall by 27%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥72.9b to CN¥72.2b. EPS estimate also fell from CN¥1.91 per share to CN¥1.39 per share. Net income forecast to shrink 6.1% next year vs 39% growth forecast for Chemicals industry in China . Consensus price target broadly unchanged at CN¥16.26. Share price fell 4.4% to CN¥13.22 over the past week.お知らせ • Feb 17Tongkun Group Co., Ltd. (SHSE:601233) entered into an agreement to acquire Tongkun (Hong Kong) Investment Co., Ltd. from Tongkun Holding Group Co., Ltd for CNY 2.4 million.Tongkun Group Co., Ltd. (SHSE:601233) entered into an agreement to acquire Tongkun (Hong Kong) Investment Co., Ltd. from Tongkun Holding Group Co., Ltd for CNY 2.4 million on February 15, 2023. Tongkun Group board approves the acquisition. As of December 31, 2022, EBIT of CNY 0 million, total assets of CNY 5.15511619 million, total common equity of CNY 2.34542982 million and net income of CNY -1.93688714 million.Major Estimate Revision • Feb 04Consensus EPS estimates fall by 21%The consensus outlook for fiscal year 2022 has been updated. 2022 EPS estimate fell from CN¥1.01 to CN¥0.797 per share. Revenue forecast steady at CN¥65.5b. Net income forecast to grow 36% next year vs 41% growth forecast for Chemicals industry in China. Consensus price target of CN¥16.25 unchanged from last update. Share price was steady at CN¥15.57 over the past week.Price Target Changed • Nov 16Price target decreased to CN¥16.25Down from CN¥18.34, the current price target is an average from 7 analysts. New target price is 15% above last closing price of CN¥14.10. Stock is down 28% over the past year. The company is forecast to post earnings per share of CN¥1.06 for next year compared to CN¥3.17 last year.Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 2 independent directors (7 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Major Estimate Revision • Nov 04Consensus EPS estimates fall by 53%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥68.0b to CN¥66.9b. EPS estimate also fell from CN¥2.27 per share to CN¥1.06 per share. Net income forecast to grow 63% next year vs 44% growth forecast for Chemicals industry in China. Consensus price target down from CN¥18.34 to CN¥16.25. Share price was steady at CN¥12.52 over the past week.Price Target Changed • Nov 02Price target decreased to CN¥16.85Down from CN¥18.34, the current price target is an average from 7 analysts. New target price is 36% above last closing price of CN¥12.42. Stock is down 39% over the past year. The company is forecast to post earnings per share of CN¥1.05 for next year compared to CN¥3.17 last year.Reported Earnings • Oct 29Third quarter 2022 earnings: EPS and revenues miss analyst expectationsThird quarter 2022 results: CN¥0.15 loss per share (down from CN¥0.89 profit in 3Q 2021). Revenue: CN¥17.3b (down 14% from 3Q 2021). Net loss: CN¥366.2m (down 118% from profit in 3Q 2021). Revenue missed analyst estimates by 12%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 29Second quarter 2022 earnings: EPS and revenues miss analyst expectationsSecond quarter 2022 results: EPS: CN¥0.34 (down from CN¥1.06 in 2Q 2021). Revenue: CN¥16.9b (down 12% from 2Q 2021). Net income: CN¥798.4m (down 67% from 2Q 2021). Profit margin: 4.7% (down from 13% in 2Q 2021). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.7%. Earnings per share (EPS) also missed analyst estimates by 58%. Over the next year, revenue is forecast to grow 23%, compared to a 40% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Major Estimate Revision • Aug 25Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from CN¥2.92 to CN¥2.05 per share. Revenue forecast steady at CN¥67.5b. Net income forecast to grow 18% next year vs 41% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥19.60. Share price fell 5.4% to CN¥14.62 over the past week.Price Target Changed • Jul 29Price target decreased to CN¥19.77Down from CN¥21.98, the current price target is an average from 11 analysts. New target price is 37% above last closing price of CN¥14.43. Stock is down 44% over the past year. The company is forecast to post earnings per share of CN¥2.93 for next year compared to CN¥3.17 last year.Major Estimate Revision • May 04Consensus EPS estimates fall by 13%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥68.5b to CN¥67.7b. EPS estimate also fell from CN¥3.46 per share to CN¥3.02 per share. Net income forecast to grow 7.3% next year vs 40% growth forecast for Chemicals industry in China. Consensus price target down from CN¥26.26 to CN¥21.98. Share price rose 6.2% to CN¥15.19 over the past week.Price Target Changed • Apr 30Price target decreased to CN¥22.94Down from CN¥26.26, the current price target is an average from 11 analysts. New target price is 51% above last closing price of CN¥15.19. Stock is down 34% over the past year. The company is forecast to post earnings per share of CN¥2.76 for next year compared to CN¥3.17 last year.Reported Earnings • Apr 28First quarter 2022 earnings: EPS and revenues miss analyst expectationsFirst quarter 2022 results: EPS: CN¥0.62 (down from CN¥0.76 in 1Q 2021). Revenue: CN¥13.0b (up 17% from 1Q 2021). Net income: CN¥1.50b (down 13% from 1Q 2021). Profit margin: 12% (down from 15% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 4.4%. Earnings per share (EPS) also missed analyst estimates by 5.0%. Over the next year, revenue is forecast to grow 13%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Major Estimate Revision • Mar 18Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from CN¥3.74 to CN¥2.46 per share. Revenue forecast steady at CN¥66.7b. Net income forecast to shrink 19% next year vs 47% growth forecast for Chemicals industry in China . Consensus price target down from CN¥28.43 to CN¥27.37. Share price was steady at CN¥17.21 over the past week.Reported Earnings • Mar 13Full year 2021 earnings: EPS and revenues miss analyst expectationsFull year 2021 results: EPS: CN¥3.17 (up from CN¥1.52 in FY 2020). Revenue: CN¥60.1b (up 31% from FY 2020). Net income: CN¥7.32b (up 157% from FY 2020). Profit margin: 12% (up from 6.2% in FY 2020). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 2.9%. Earnings per share (EPS) also missed analyst estimates by 5.0%. Over the next year, revenue is forecast to grow 11%, compared to a 46% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Mar 07Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to CN¥17.80, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 37% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥7.22 per share.Price Target Changed • Nov 07Price target decreased to CN¥29.57Down from CN¥31.89, the current price target is an average from 12 analysts. New target price is 56% above last closing price of CN¥18.90. Stock is up 18% over the past year. The company is forecast to post earnings per share of CN¥3.37 for next year compared to CN¥1.52 last year.Reported Earnings • Oct 31Third quarter 2021 earnings released: EPS CN¥0.89 (vs CN¥0.43 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥20.2b (up 76% from 3Q 2020). Net income: CN¥2.03b (up 157% from 3Q 2020). Profit margin: 10% (up from 6.9% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.Price Target Changed • Oct 31Price target decreased to CN¥31.52Down from CN¥33.92, the current price target is an average from 12 analysts. New target price is 58% above last closing price of CN¥19.94. Stock is up 32% over the past year. The company is forecast to post earnings per share of CN¥3.30 for next year compared to CN¥1.52 last year.Price Target Changed • Aug 21Price target increased to CN¥33.92Up from CN¥31.66, the current price target is an average from 11 analysts. New target price is 32% above last closing price of CN¥25.63. Stock is up 55% over the past year.Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS CN¥1.06 (vs CN¥0.32 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥19.1b (up 40% from 2Q 2020). Net income: CN¥2.42b (up 314% from 2Q 2020). Profit margin: 13% (up from 4.3% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 18% per year whereas the company’s share price has increased by 15% per year.Price Target Changed • Jul 21Price target increased to CN¥31.31Up from CN¥29.04, the current price target is an average from 13 analysts. New target price is 17% above last closing price of CN¥26.75. Stock is up 72% over the past year.Major Estimate Revision • Jul 17Consensus EPS estimates increase to CN¥2.82The consensus outlook for earnings per share (EPS) in 2021 has improved. 2021 revenue forecast increased from CN¥55.0b to CN¥55.9b. EPS estimate increased from CN¥2.47 to CN¥2.82 per share. Net income forecast to grow 50% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target up from CN¥27.63 to CN¥29.28. Share price rose 12% to CN¥27.39 over the past week.Reported Earnings • Apr 17Full year 2020 earnings released: EPS CN¥1.52 (vs CN¥1.57 in FY 2019)The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: CN¥45.8b (down 9.4% from FY 2019). Net income: CN¥2.85b (down 1.3% from FY 2019). Profit margin: 6.2% (up from 5.7% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 7% per year.Valuation Update With 7 Day Price Move • Mar 25Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥19.92, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 30% over the past three years.Valuation Update With 7 Day Price Move • Feb 11Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥28.69, the stock is trading at a trailing P/E ratio of 23.7x, up from the previous P/E ratio of 20.4x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 69%.株主還元601233CN ChemicalsCN 市場7D1.5%7.3%3.2%1Y85.6%30.5%11.2%株主還元を見る業界別リターン: 601233過去 1 年間で30.5 % の収益を上げたCN Chemicals業界を上回りました。リターン対市場: 601233過去 1 年間で11.2 % の収益を上げたCN市場を上回りました。価格変動Is 601233's price volatile compared to industry and market?601233 volatility601233 Average Weekly Movement8.7%Chemicals Industry Average Movement7.9%Market Average Movement7.4%10% most volatile stocks in CN Market12.5%10% least volatile stocks in CN Market4.4%安定した株価: 601233 、 CN市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 601233の 週次ボラティリティ ( 9% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト198233,639Shengjun Lizjtkgf.com同君集団有限公司は中国でポリエステルフィラメント糸を製造・販売している。同社はGOLDENCOCKとTongkunのブランド名で、ポリエステル先延伸糸、低スパムデックス糸、総延伸糸、複合糸、スパンデックスカバー糸、2成分系弾性糸、ポリブチレンテレフタレートマット高弾性糸、高機能縫製糸としての中強ポリエステル糸、イミテーション麻糸、ブランケットプラッシュヤーン、カチオン変性ポリエステルなど様々なポリエステルフィラメント糸を提供している。また、南米、ヨーロッパ、中東、南アフリカ、韓国、ベトナム、および海外に製品を輸出している。同社は1982年に設立され、中国の桐郷に本社を置いている。もっと見るTongkun Group Co., Ltd. 基礎のまとめTongkun Group の収益と売上を時価総額と比較するとどうか。601233 基礎統計学時価総額CN¥55.01b収益（TTM）CN¥3.32b売上高(TTM)CN¥97.83b16.6xPER（株価収益率0.6xP/Sレシオ601233 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計601233 損益計算書（TTM）収益CN¥97.83b売上原価CN¥92.10b売上総利益CN¥5.73bその他の費用CN¥2.41b収益CN¥3.32b直近の収益報告Mar 31, 2026次回決算日Aug 26, 2026一株当たり利益（EPS）1.41グロス・マージン5.86%純利益率3.39%有利子負債／自己資本比率158.8%601233 の長期的なパフォーマンスは？過去の実績と比較を見る配当金0.5%現在の配当利回り9%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/12 02:37終値2026/08/12 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Tongkun Group Co., Ltd. 6 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。9 アナリスト機関Kaiming FuChina International Capital Corporation LimitedXiaotian XuChina International Capital Corporation LimitedMarcus ChuGoldman Sachs6 その他のアナリストを表示
Valuation Update With 7 Day Price Move • Jul 13Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥19.31, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 37% over the past three years.
Declared Dividend • Jul 06Dividend increased to CN¥0.12Dividend of CN¥0.12 is 20% higher than last year. Ex-date: 9th July 2026 Payment date: 9th July 2026 Dividend yield will be 0.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (9% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 5.3% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 52% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
New Risk • Jul 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.8% average weekly change). Large one-off items impacting financial results.
お知らせ • Jun 30Tongkun Group Co., Ltd. to Report First Half, 2026 Results on Aug 26, 2026Tongkun Group Co., Ltd. announced that they will report first half, 2026 results on Aug 26, 2026
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥23.47, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 80% over the past three years.
New Risk • May 09New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (9.0% average weekly change). Large one-off items impacting financial results.
Valuation Update With 7 Day Price Move • Jul 13Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥19.31, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 37% over the past three years.
Declared Dividend • Jul 06Dividend increased to CN¥0.12Dividend of CN¥0.12 is 20% higher than last year. Ex-date: 9th July 2026 Payment date: 9th July 2026 Dividend yield will be 0.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (9% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 5.3% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 52% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
New Risk • Jul 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.8% average weekly change). Large one-off items impacting financial results.
お知らせ • Jun 30Tongkun Group Co., Ltd. to Report First Half, 2026 Results on Aug 26, 2026Tongkun Group Co., Ltd. announced that they will report first half, 2026 results on Aug 26, 2026
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥23.47, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 80% over the past three years.
New Risk • May 09New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (9.0% average weekly change). Large one-off items impacting financial results.
Major Estimate Revision • May 05Consensus EPS estimates increase by 31%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from CN¥103.8b to CN¥113.5b. EPS estimate increased from CN¥1.36 to CN¥1.79 per share. Net income forecast to grow 32% next year vs 58% growth forecast for Chemicals industry in China. Consensus price target up from CN¥24.85 to CN¥27.74. Share price rose 16% to CN¥24.21 over the past week.
Price Target Changed • Apr 30Price target increased by 12% to CN¥27.74Up from CN¥24.85, the current price target is an average from 4 analysts. New target price is 15% above last closing price of CN¥24.21. Stock is up 123% over the past year. The company is forecast to post earnings per share of CN¥1.79 for next year compared to CN¥0.86 last year.
Reported Earnings • Apr 29First quarter 2026 earnings released: EPS: CN¥0.80 (vs CN¥0.26 in 1Q 2025)First quarter 2026 results: EPS: CN¥0.80 (up from CN¥0.26 in 1Q 2025). Revenue: CN¥23.4b (up 20% from 1Q 2025). Net income: CN¥1.90b (up 211% from 1Q 2025). Profit margin: 8.1% (up from 3.1% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.
お知らせ • Apr 29Tongkun Group Co., Ltd., Annual General Meeting, May 20, 2026Tongkun Group Co., Ltd., Annual General Meeting, May 20, 2026, at 14:00 China Standard Time. Location: No. 518, Fenghuanghu Avenue, Tongxiang, Zhejiang China
お知らせ • Mar 30Tongkun Group Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026Tongkun Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026
Valuation Update With 7 Day Price Move • Mar 09Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to CN¥20.46, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 25x in the Chemicals industry in China. Total returns to shareholders of 39% over the past three years.
New Risk • Mar 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (8.7% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.8% average weekly change). Large one-off items impacting financial results.
お知らせ • Dec 26Tongkun Group Co., Ltd. to Report Fiscal Year 2025 Results on Apr 22, 2026Tongkun Group Co., Ltd. announced that they will report fiscal year 2025 results on Apr 22, 2026
Reported Earnings • Oct 30Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: EPS: CN¥0.19 (up from CN¥0.024 loss in 3Q 2024). Revenue: CN¥23.2b (down 17% from 3Q 2024). Net income: CN¥452.1m (up CN¥510.7m from 3Q 2024). Profit margin: 1.9% (up from net loss in 3Q 2024). Revenue missed analyst estimates by 5.0%. Earnings per share (EPS) also missed analyst estimates by 15%. Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
お知らせ • Sep 30Tongkun Group Co., Ltd. to Report Q3, 2025 Results on Oct 30, 2025Tongkun Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025
Price Target Changed • Sep 17Price target increased by 8.8% to CN¥16.35Up from CN¥15.03, the current price target is an average from 4 analysts. New target price is 13% above last closing price of CN¥14.45. Stock is up 41% over the past year. The company is forecast to post earnings per share of CN¥0.94 for next year compared to CN¥0.51 last year.
Price Target Changed • Aug 31Price target increased by 13% to CN¥15.53Up from CN¥13.71, the current price target is an average from 6 analysts. New target price is 5.8% above last closing price of CN¥14.67. Stock is up 23% over the past year. The company is forecast to post earnings per share of CN¥0.88 for next year compared to CN¥0.51 last year.
Major Estimate Revision • Aug 30Consensus EPS estimates increase by 11%, revenue downgradedThe consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast fell from CN¥100.2b to CN¥91.3b. EPS estimate rose from CN¥0.821 to CN¥0.913. Net income forecast to grow 98% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target up from CN¥13.71 to CN¥14.56. Share price rose 2.8% to CN¥14.67 over the past week.
Declared Dividend • Jul 06Dividend increased to CN¥0.10Dividend of CN¥0.10 is 133% higher than last year. Ex-date: 10th July 2025 Payment date: 10th July 2025 Dividend yield will be 0.9%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (19% earnings payout ratio) and cash flows (19% cash payout ratio). The dividend has increased by an average of 15% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 155% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Jun 30Tongkun Group Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025Tongkun Group Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025
New Risk • Apr 30New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.2% Last year net profit margin: 2.1% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.8x net interest cover). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.2% net profit margin).
New Risk • Apr 29New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 0.9% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.5x net interest cover). Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results.
Reported Earnings • Apr 28Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2024 results: EPS: CN¥0.51 (up from CN¥0.34 in FY 2023). Revenue: CN¥101.3b (up 23% from FY 2023). Net income: CN¥1.20b (up 51% from FY 2023). Profit margin: 1.2% (up from 1.0% in FY 2023). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 6.6%. Earnings per share (EPS) missed analyst estimates by 9.0%. Revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance.
お知らせ • Apr 26Tongkun Group Co., Ltd., Annual General Meeting, May 20, 2025Tongkun Group Co., Ltd., Annual General Meeting, May 20, 2025, at 14:00 China Standard Time. Location: No. 518, Fenghuanghu Avenue, Tongxiang, Zhejiang China
Valuation Update With 7 Day Price Move • Apr 09Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥10.00, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 20x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years.
お知らせ • Mar 28Tongkun Group Co., Ltd. to Report Q1, 2025 Results on Apr 30, 2025Tongkun Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 30, 2025
お知らせ • Dec 27Tongkun Group Co., Ltd. to Report Fiscal Year 2024 Results on Apr 26, 2025Tongkun Group Co., Ltd. announced that they will report fiscal year 2024 results on Apr 26, 2025
Major Estimate Revision • Nov 06Consensus EPS estimates fall by 41%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from CN¥93.3b to CN¥95.5b. EPS estimate fell from CN¥1.03 to CN¥0.612 per share. Net income forecast to grow 235% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target down from CN¥15.88 to CN¥15.13. Share price rose 4.0% to CN¥12.36 over the past week.
Reported Earnings • Oct 31Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behindThird quarter 2024 results: CN¥0.024 loss per share (down from CN¥0.43 profit in 3Q 2023). Revenue: CN¥27.8b (up 12% from 3Q 2023). Net loss: CN¥58.6m (down 107% from profit in 3Q 2023). Revenue exceeded analyst estimates by 20%. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 5.5% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.
お知らせ • Sep 30Tongkun Group Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024Tongkun Group Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥12.37, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 42% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥12.14 per share.
Major Estimate Revision • Sep 04Consensus EPS estimates fall by 15%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate fell from CN¥1.24 to CN¥1.05 per share. Revenue forecast steady at CN¥92.0b. Net income forecast to grow 85% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target down from CN¥16.87 to CN¥15.88. Share price fell 2.1% to CN¥11.45 over the past week.
Price Target Changed • Aug 30Price target decreased by 8.4% to CN¥15.45Down from CN¥16.87, the current price target is an average from 5 analysts. New target price is 30% above last closing price of CN¥11.89. Stock is down 22% over the past year. The company is forecast to post earnings per share of CN¥1.06 for next year compared to CN¥0.34 last year.
Reported Earnings • Aug 29Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2024 results: EPS: CN¥0.21 (down from CN¥0.21 in 2Q 2023). Revenue: CN¥27.1b (up 29% from 2Q 2023). Net income: CN¥485.3m (down 19% from 2Q 2023). Profit margin: 1.8% (down from 2.8% in 2Q 2023). Revenue exceeded analyst estimates by 18%. Earnings per share (EPS) missed analyst estimates by 42%. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance.
Buy Or Sell Opportunity • Jul 31Now 26% overvalued after recent price riseOver the last 90 days, the stock has risen 2.0% to CN¥14.05. The fair value is estimated to be CN¥11.12, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 15% in 2 years. Earnings are forecast to grow by 148% in the next 2 years.
Buy Or Sell Opportunity • Jul 11Now 23% overvalued after recent price riseOver the last 90 days, the stock has risen 9.6% to CN¥15.06. The fair value is estimated to be CN¥12.19, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 14% in 2 years. Earnings are forecast to grow by 151% in the next 2 years.
お知らせ • Jun 28Tongkun Group Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024Tongkun Group Co., Ltd. announced that they will report first half, 2024 results on Aug 29, 2024
お知らせ • Apr 29Tongkun Group Co., Ltd., Annual General Meeting, May 21, 2024Tongkun Group Co., Ltd., Annual General Meeting, May 21, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Tongxiang, Zhejiang China
Reported Earnings • Apr 27Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2023 results: EPS: CN¥0.34 (up from CN¥0.055 in FY 2022). Revenue: CN¥82.6b (up 33% from FY 2022). Net income: CN¥797.0m (up CN¥666.8m from FY 2022). Profit margin: 1.0% (up from 0.2% in FY 2022). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 4.4%. Earnings per share (EPS) missed analyst estimates by 48%. Revenue is forecast to grow 6.6% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 54 percentage points per year, which is a significant difference in performance.
お知らせ • Mar 30Tongkun Group Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024Tongkun Group Co., Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024
お知らせ • Dec 30Tongkun Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024Tongkun Group Co., Ltd. announced that they will report fiscal year 2023 results on Apr 27, 2024
Reported Earnings • Oct 29Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behindThird quarter 2023 results: EPS: CN¥0.43 (up from CN¥0.15 loss in 3Q 2022). Revenue: CN¥24.8b (up 43% from 3Q 2022). Net income: CN¥798.3m (up CN¥1.16b from 3Q 2022). Profit margin: 3.2% (up from net loss in 3Q 2022). The move to profitability was driven by higher revenue. Revenue exceeded analyst estimates by 48%. Earnings per share (EPS) missed analyst estimates by 27%. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
お知らせ • Sep 30Tongkun Group Co., Ltd. to Report Q3, 2023 Results on Oct 28, 2023Tongkun Group Co., Ltd. announced that they will report Q3, 2023 results at 3:00 PM, China Standard Time on Oct 28, 2023
New Risk • Sep 26New major risk - Revenue and earnings growthEarnings have declined by 1.7% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (16% operating cash flow to total debt). Earnings have declined by 1.7% per year over the past 5 years.
Price Target Changed • Sep 19Price target increased by 8.6% to CN¥17.33Up from CN¥15.96, the current price target is an average from 8 analysts. New target price is 13% above last closing price of CN¥15.28. Stock is up 5.7% over the past year. The company is forecast to post earnings per share of CN¥0.80 for next year compared to CN¥0.055 last year.
Price Target Changed • Sep 07Price target increased by 8.8% to CN¥16.82Up from CN¥15.46, the current price target is an average from 9 analysts. New target price is 9.8% above last closing price of CN¥15.32. Stock is up 3.9% over the past year. The company is forecast to post earnings per share of CN¥0.91 for next year compared to CN¥0.055 last year.
Reported Earnings • Aug 30Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2023 results: EPS: CN¥0.21 (down from CN¥0.34 in 2Q 2022). Revenue: CN¥21.0b (up 25% from 2Q 2022). Net income: CN¥595.5m (down 25% from 2Q 2022). Profit margin: 2.8% (down from 4.7% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 75%. Earnings per share (EPS) missed analyst estimates by 54%. Revenue is forecast to grow 9.9% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
お知らせ • Jun 28Tongkun Group Co., Ltd. to Report First Half, 2023 Results on Aug 30, 2023Tongkun Group Co., Ltd. announced that they will report first half, 2023 results on Aug 30, 2023
Price Target Changed • May 29Price target decreased by 10% to CN¥14.56Down from CN¥16.26, the current price target is an average from 6 analysts. New target price is 20% above last closing price of CN¥12.13. Stock is down 28% over the past year. The company is forecast to post earnings per share of CN¥1.30 for next year compared to CN¥0.055 last year.
Price Target Changed • May 12Price target decreased by 7.3% to CN¥15.08Down from CN¥16.26, the current price target is an average from 6 analysts. New target price is 19% above last closing price of CN¥12.72. Stock is down 17% over the past year. The company is forecast to post earnings per share of CN¥1.36 for next year compared to CN¥0.055 last year.
Reported Earnings • Apr 26Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: CN¥0.055 (down from CN¥3.23 in FY 2021). Revenue: CN¥62.0b (up 4.8% from FY 2021). Net income: CN¥130.2m (down 98% from FY 2021). Profit margin: 0.2% (down from 13% in FY 2021). Revenue missed analyst estimates by 2.7%. Earnings per share (EPS) also missed analyst estimates by 93%. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 4% per year and the company’s share price has also increased by 4% per year.
Major Estimate Revision • Apr 23Consensus EPS estimates fall by 27%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥72.9b to CN¥72.2b. EPS estimate also fell from CN¥1.91 per share to CN¥1.39 per share. Net income forecast to shrink 6.1% next year vs 39% growth forecast for Chemicals industry in China . Consensus price target broadly unchanged at CN¥16.26. Share price fell 4.4% to CN¥13.22 over the past week.
お知らせ • Feb 17Tongkun Group Co., Ltd. (SHSE:601233) entered into an agreement to acquire Tongkun (Hong Kong) Investment Co., Ltd. from Tongkun Holding Group Co., Ltd for CNY 2.4 million.Tongkun Group Co., Ltd. (SHSE:601233) entered into an agreement to acquire Tongkun (Hong Kong) Investment Co., Ltd. from Tongkun Holding Group Co., Ltd for CNY 2.4 million on February 15, 2023. Tongkun Group board approves the acquisition. As of December 31, 2022, EBIT of CNY 0 million, total assets of CNY 5.15511619 million, total common equity of CNY 2.34542982 million and net income of CNY -1.93688714 million.
Major Estimate Revision • Feb 04Consensus EPS estimates fall by 21%The consensus outlook for fiscal year 2022 has been updated. 2022 EPS estimate fell from CN¥1.01 to CN¥0.797 per share. Revenue forecast steady at CN¥65.5b. Net income forecast to grow 36% next year vs 41% growth forecast for Chemicals industry in China. Consensus price target of CN¥16.25 unchanged from last update. Share price was steady at CN¥15.57 over the past week.
Price Target Changed • Nov 16Price target decreased to CN¥16.25Down from CN¥18.34, the current price target is an average from 7 analysts. New target price is 15% above last closing price of CN¥14.10. Stock is down 28% over the past year. The company is forecast to post earnings per share of CN¥1.06 for next year compared to CN¥3.17 last year.
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 2 independent directors (7 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Major Estimate Revision • Nov 04Consensus EPS estimates fall by 53%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥68.0b to CN¥66.9b. EPS estimate also fell from CN¥2.27 per share to CN¥1.06 per share. Net income forecast to grow 63% next year vs 44% growth forecast for Chemicals industry in China. Consensus price target down from CN¥18.34 to CN¥16.25. Share price was steady at CN¥12.52 over the past week.
Price Target Changed • Nov 02Price target decreased to CN¥16.85Down from CN¥18.34, the current price target is an average from 7 analysts. New target price is 36% above last closing price of CN¥12.42. Stock is down 39% over the past year. The company is forecast to post earnings per share of CN¥1.05 for next year compared to CN¥3.17 last year.
Reported Earnings • Oct 29Third quarter 2022 earnings: EPS and revenues miss analyst expectationsThird quarter 2022 results: CN¥0.15 loss per share (down from CN¥0.89 profit in 3Q 2021). Revenue: CN¥17.3b (down 14% from 3Q 2021). Net loss: CN¥366.2m (down 118% from profit in 3Q 2021). Revenue missed analyst estimates by 12%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 29Second quarter 2022 earnings: EPS and revenues miss analyst expectationsSecond quarter 2022 results: EPS: CN¥0.34 (down from CN¥1.06 in 2Q 2021). Revenue: CN¥16.9b (down 12% from 2Q 2021). Net income: CN¥798.4m (down 67% from 2Q 2021). Profit margin: 4.7% (down from 13% in 2Q 2021). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.7%. Earnings per share (EPS) also missed analyst estimates by 58%. Over the next year, revenue is forecast to grow 23%, compared to a 40% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Major Estimate Revision • Aug 25Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from CN¥2.92 to CN¥2.05 per share. Revenue forecast steady at CN¥67.5b. Net income forecast to grow 18% next year vs 41% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥19.60. Share price fell 5.4% to CN¥14.62 over the past week.
Price Target Changed • Jul 29Price target decreased to CN¥19.77Down from CN¥21.98, the current price target is an average from 11 analysts. New target price is 37% above last closing price of CN¥14.43. Stock is down 44% over the past year. The company is forecast to post earnings per share of CN¥2.93 for next year compared to CN¥3.17 last year.
Major Estimate Revision • May 04Consensus EPS estimates fall by 13%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥68.5b to CN¥67.7b. EPS estimate also fell from CN¥3.46 per share to CN¥3.02 per share. Net income forecast to grow 7.3% next year vs 40% growth forecast for Chemicals industry in China. Consensus price target down from CN¥26.26 to CN¥21.98. Share price rose 6.2% to CN¥15.19 over the past week.
Price Target Changed • Apr 30Price target decreased to CN¥22.94Down from CN¥26.26, the current price target is an average from 11 analysts. New target price is 51% above last closing price of CN¥15.19. Stock is down 34% over the past year. The company is forecast to post earnings per share of CN¥2.76 for next year compared to CN¥3.17 last year.
Reported Earnings • Apr 28First quarter 2022 earnings: EPS and revenues miss analyst expectationsFirst quarter 2022 results: EPS: CN¥0.62 (down from CN¥0.76 in 1Q 2021). Revenue: CN¥13.0b (up 17% from 1Q 2021). Net income: CN¥1.50b (down 13% from 1Q 2021). Profit margin: 12% (down from 15% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 4.4%. Earnings per share (EPS) also missed analyst estimates by 5.0%. Over the next year, revenue is forecast to grow 13%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Major Estimate Revision • Mar 18Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from CN¥3.74 to CN¥2.46 per share. Revenue forecast steady at CN¥66.7b. Net income forecast to shrink 19% next year vs 47% growth forecast for Chemicals industry in China . Consensus price target down from CN¥28.43 to CN¥27.37. Share price was steady at CN¥17.21 over the past week.
Reported Earnings • Mar 13Full year 2021 earnings: EPS and revenues miss analyst expectationsFull year 2021 results: EPS: CN¥3.17 (up from CN¥1.52 in FY 2020). Revenue: CN¥60.1b (up 31% from FY 2020). Net income: CN¥7.32b (up 157% from FY 2020). Profit margin: 12% (up from 6.2% in FY 2020). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 2.9%. Earnings per share (EPS) also missed analyst estimates by 5.0%. Over the next year, revenue is forecast to grow 11%, compared to a 46% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Mar 07Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to CN¥17.80, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 37% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥7.22 per share.
Price Target Changed • Nov 07Price target decreased to CN¥29.57Down from CN¥31.89, the current price target is an average from 12 analysts. New target price is 56% above last closing price of CN¥18.90. Stock is up 18% over the past year. The company is forecast to post earnings per share of CN¥3.37 for next year compared to CN¥1.52 last year.
Reported Earnings • Oct 31Third quarter 2021 earnings released: EPS CN¥0.89 (vs CN¥0.43 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥20.2b (up 76% from 3Q 2020). Net income: CN¥2.03b (up 157% from 3Q 2020). Profit margin: 10% (up from 6.9% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.
Price Target Changed • Oct 31Price target decreased to CN¥31.52Down from CN¥33.92, the current price target is an average from 12 analysts. New target price is 58% above last closing price of CN¥19.94. Stock is up 32% over the past year. The company is forecast to post earnings per share of CN¥3.30 for next year compared to CN¥1.52 last year.
Price Target Changed • Aug 21Price target increased to CN¥33.92Up from CN¥31.66, the current price target is an average from 11 analysts. New target price is 32% above last closing price of CN¥25.63. Stock is up 55% over the past year.
Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS CN¥1.06 (vs CN¥0.32 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥19.1b (up 40% from 2Q 2020). Net income: CN¥2.42b (up 314% from 2Q 2020). Profit margin: 13% (up from 4.3% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 18% per year whereas the company’s share price has increased by 15% per year.
Price Target Changed • Jul 21Price target increased to CN¥31.31Up from CN¥29.04, the current price target is an average from 13 analysts. New target price is 17% above last closing price of CN¥26.75. Stock is up 72% over the past year.
Major Estimate Revision • Jul 17Consensus EPS estimates increase to CN¥2.82The consensus outlook for earnings per share (EPS) in 2021 has improved. 2021 revenue forecast increased from CN¥55.0b to CN¥55.9b. EPS estimate increased from CN¥2.47 to CN¥2.82 per share. Net income forecast to grow 50% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target up from CN¥27.63 to CN¥29.28. Share price rose 12% to CN¥27.39 over the past week.
Reported Earnings • Apr 17Full year 2020 earnings released: EPS CN¥1.52 (vs CN¥1.57 in FY 2019)The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: CN¥45.8b (down 9.4% from FY 2019). Net income: CN¥2.85b (down 1.3% from FY 2019). Profit margin: 6.2% (up from 5.7% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 7% per year.
Valuation Update With 7 Day Price Move • Mar 25Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥19.92, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 30% over the past three years.
Valuation Update With 7 Day Price Move • Feb 11Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥28.69, the stock is trading at a trailing P/E ratio of 23.7x, up from the previous P/E ratio of 20.4x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 69%.
